The enteric softgel capsules market was valued at $ 2.33 billion in 2022 and is estimated to reach $ 3.46 billion by 2032, exhibiting a CAGR of 4.0% from 2023 to 2032. Enteric softgel capsules represent pharmaceutical or nutraceutical formulations known for their soft, easily ingestible gelatinous exteriors. These capsules feature a specialized enteric coating, serving as a protective barrier against stomach acids and facilitating a controlled release in the intestine.
The growth of the enteric softgel capsules market is strongly driven by the surging adoption of nutraceutical supplements and the benefits associated with enteric-coated softgel capsules. With an escalating focus on health, the demand for nutritional supplements is on the rise, contributing to the robust expansion of the nutraceutical industry. Enteric softgel capsules, distinguished by their precisely tailored enteric coatings, emerge as a strategic solution for delivering delicate active ingredients, safeguarding them from the harsh acidic conditions of the stomach. This targeted release mechanism optimizes absorption in the intestine, thereby elevating the bioavailability of pharmaceuticals and nutrients.The adaptability of enteric softgel capsules to delicate formulations positions them as a preferred choice for manufacturers aiming to ensure the effective and efficient delivery of health-enhancing compounds.
In addition, the merits of enteric-coated softgel capsules extend to enhanced patient compliance, effectively reducing the incidence of gastrointestinal discomfort. The capacity to mitigate side effects fosters greater overall tolerability of supplements and medications, promoting consistent usage. Furthermore, the adaptability of enteric softgel capsules to a diverse array of formulations further propels their popularity across pharmaceutical and nutraceutical applications. The expanding nutraceutical sector and the inherent advantages of enteric-coated softgel capsules synergize seamlessly, reflecting market growth driven by the evolving preferences of health-conscious consumers seeking efficacious and well-tolerated health solutions.
The enteric softgel capsules market is segmented on the basis of application, distribution channel, and region. On the basis of application, the market is segmented into health supplements and pharmaceuticals. On the basis of distribution channel, the market is segmented supermarket & hypermarket, pharmacy & drug store, and online provider. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LA (Brazil, Colombia, Argentina, and rest of LA) and MEA (GCC, South Africa, North Africa and rest of MEA).
The major key players that operate in the global enteric softgel capsules market are Catalent, Inc., Sirio Pharma Co., Ltd., Fuji Capsules Co. Ltd., InovoBiologic Inc, NOW Foods Inc., Gelita AG, CAPTEK Softgel International Inc., Viva Pharmaceutical., Aenova Group, Procaps Group. The key players have adopted product launch as the key strategy to expand their product portfolio.
The growth of the enteric softgel capsules market is strongly driven by the surging adoption of nutraceutical supplements and the benefits associated with enteric-coated softgel capsules. With an escalating focus on health, the demand for nutritional supplements is on the rise, contributing to the robust expansion of the nutraceutical industry. Enteric softgel capsules, distinguished by their precisely tailored enteric coatings, emerge as a strategic solution for delivering delicate active ingredients, safeguarding them from the harsh acidic conditions of the stomach. This targeted release mechanism optimizes absorption in the intestine, thereby elevating the bioavailability of pharmaceuticals and nutrients.The adaptability of enteric softgel capsules to delicate formulations positions them as a preferred choice for manufacturers aiming to ensure the effective and efficient delivery of health-enhancing compounds.
In addition, the merits of enteric-coated softgel capsules extend to enhanced patient compliance, effectively reducing the incidence of gastrointestinal discomfort. The capacity to mitigate side effects fosters greater overall tolerability of supplements and medications, promoting consistent usage. Furthermore, the adaptability of enteric softgel capsules to a diverse array of formulations further propels their popularity across pharmaceutical and nutraceutical applications. The expanding nutraceutical sector and the inherent advantages of enteric-coated softgel capsules synergize seamlessly, reflecting market growth driven by the evolving preferences of health-conscious consumers seeking efficacious and well-tolerated health solutions.
The enteric softgel capsules market is segmented on the basis of application, distribution channel, and region. On the basis of application, the market is segmented into health supplements and pharmaceuticals. On the basis of distribution channel, the market is segmented supermarket & hypermarket, pharmacy & drug store, and online provider. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LA (Brazil, Colombia, Argentina, and rest of LA) and MEA (GCC, South Africa, North Africa and rest of MEA).
The major key players that operate in the global enteric softgel capsules market are Catalent, Inc., Sirio Pharma Co., Ltd., Fuji Capsules Co. Ltd., InovoBiologic Inc, NOW Foods Inc., Gelita AG, CAPTEK Softgel International Inc., Viva Pharmaceutical., Aenova Group, Procaps Group. The key players have adopted product launch as the key strategy to expand their product portfolio.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteric softgel capsules market analysis from 2022 to 2032 to identify the prevailing enteric softgel capsules market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the enteric softgel capsules market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global enteric softgel capsules market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Application
- Health Supplements
- Pharmaceuticals
By Distribution Channel
- Supermarket and Hypermarket
- Pharmacy and Drug store
- Online Provider
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Colombia
- Argentina
- Rest Of La
- Middle East and Africa
- Gcc
- South Africa
- North Africa
- Rest Of Mea
Key Market Players
- Catalent, Inc.
- sirio pharma co., ltd.
- Fuji Capsules Co. Ltd.
- InovoBiologic Inc
- NOW Foods Inc.
- Gelita AG.
- Captek Softgel International Inc.
- Viva Pharmaceuticals
- aenova group
- Procaps Group
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION
CHAPTER 5: ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 6: ENTERIC SOFTGEL CAPSULES MARKET, BY REGION
CHAPTER 7: COMPETITIVE LANDSCAPE
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Catalent, Inc.
- sirio pharma co., ltd.
- Fuji Capsules Co. Ltd.
- InovoBiologic Inc
- NOW Foods Inc.
- Gelita AG.
- Captek Softgel International Inc.
- Viva Pharmaceuticals
- aenova group
- Procaps Group
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
